As of 2025-12-23, the Intrinsic Value of Atossa Therapeutics Inc (ATOS) is -0.94 USD. This Atossa valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.72 USD, the upside of Atossa Therapeutics Inc is -231.62%.
Based on its market price of 0.72 USD and our intrinsic valuation, Atossa Therapeutics Inc (ATOS) is overvalued by 231.62%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.94 - -0.94 | -0.94 | -231.62% |
| P/E | (0.78) - (2.73) | (1.76) | -345.5% |
| DDM - Stable | (1.07) - (5.14) | (3.11) | -533.2% |
| DDM - Multi | (0.80) - (3.19) | (1.30) | -281.9% |
| Market Cap (mil) | 114.65 |
| Beta | 2.00 |
| Outstanding shares (mil) | 159.86 |
| Enterprise Value (mil) | 62.81 |
| Market risk premium | 4.60% |
| Cost of Equity | 11.80% |
| Cost of Debt | 5.00% |
| WACC | 7.74% |